Diadexus, Inc. is a diagnostics company. The Company is engaged in developing and commercializing products that deliver healthcare providers with relevant information to assist in the management of their patients throughout the course of cardiac disease. Its capabilities include manufacturing, assay development, Food and Drug Administration (FDA) regulatory clearance, and marketing and selling products. Its commercially-available products consist of two FDA-cleared tests to measure Lp-PLA2: the PLAC Test ELISA Kit (the PLAC ELISA Test) and the PLAC Test for Lp-PLA2 Activity (the PLAC Activity Test). Its other products include proADM; proET-1, which aids in predication of heart failure, and proANP, which aids in predication of heart failure. The Company sells its diagnostic products to laboratories and promotes these products to the laboratories' sales representatives, as well as directly to healthcare providers.
Industry, Sector and Symbol:
- Sector: N/A
- Industry: N/A
- Sub-Industry: N/A
- Symbol: OTCMKTS:DDXS
- CUSIP: N/A
- Web: N/A
- 50 Day Moving Avg: $1.11
- 200 Day Moving Avg: $1.54
- 52 Week Range: $0.01 - $5.40
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -0.01
- P/E Growth: 0.00
- Average Volume: 24,020 shs.
Frequently Asked Questions for diaDexus (OTCMKTS:DDXS)
What is diaDexus' stock symbol?
diaDexus trades on the OTCMKTS under the ticker symbol "DDXS."
How were diaDexus' earnings last quarter?
diaDexus, Inc. (OTCMKTS:DDXS) announced its earnings results on Monday, October, 26th. The company reported ($0.34) earnings per share for the quarter, beating the consensus estimate of ($0.69) by $0.35. View diaDexus' Earnings History.
Who are some of diaDexus' key competitors?
Some companies that are related to diaDexus include Lundin Petroleum A Spon (LNDNY), Banco Popolare (BPSAY), DAILY MAIL&GEN TST SPON (DMTGY), African Barrick Gold Ltd (ABGLY), Solvay S.A. (SVYZY), Tencent Holdings Ltd (TCEHY), Nestle SA (NSRGY), Cable & Wireless Communications Plc (CWIXF), L'Oreal SA (LRLCY), Naspers Limited (NPSNY), Softbank Corp. (Japan) (SFTBY), Allianz SE (AZSEY), Basf Se (BASFY), Volkswagen AG (VLKAY), Reckitt Benckiser Group Plc-ADR (RBGLY), Australia and New Zealand Banking (ANZBY), National Australia Bank (NABZY) and Glencore International PLC, St. Helier (GLCNF).
Who are diaDexus' key executives?
diaDexus' management team includes the folowing people:
- Lori F. Rafield Ph.D., Chairman of the Board, Chief Executive Officer
How do I buy diaDexus stock?
Shares of diaDexus can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is diaDexus' stock price today?
MarketBeat Community Rating for diaDexus (OTCMKTS DDXS)MarketBeat's community ratings are surveys of what our community members think about diaDexus and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of diaDexus stock can currently be purchased for approximately $0.01.
Consensus Ratings for diaDexus (OTCMKTS:DDXS) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for diaDexus (OTCMKTS:DDXS)
(Data available from 5/29/2015 forward)
|8/14/2015||Feltl & Co.||Downgrade||Buy -> Hold|
Earnings History for diaDexus (OTCMKTS:DDXS)Earnings History by Quarter for diaDexus (OTCMKTS:DDXS)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
Earnings Estimates for diaDexus (OTCMKTS:DDXS)
Current Year EPS Consensus Estimate: $-1.50 EPS
Next Year EPS Consensus Estimate: $-1.50 EPS
Dividend History for diaDexus (OTCMKTS:DDXS)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for diaDexus (OTCMKTS:DDXS)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for diaDexus (OTCMKTS:DDXS)
Latest Headlines for diaDexus (OTCMKTS:DDXS)
diaDexus (DDXS) Chart for Monday, May, 29, 2017